AdamsS. S.: The Pharmacological Properties oí Ibuprofen, an Antiinflammatory, Analgesic and Antipyretic Agent, Arch. Int. Pharmacodyn.178: 115, 1969.
2.
AdamsS. S.: Some Aspects of the Pharmacology, Metabolism, and Toxicology of Ibuprofen, Rheum. Phys. Med. (Suppl.) 10: 9 (Mar. 13) 1970.
3.
O'BrienJ. R.: Effects of Antiinflammatory Agents on Platelets, Lancet1: 894 (Apr. 27) 1968.
4.
BaeleG.: Preliminary Results of Platelet Aggregation Before and After Administration of Ibuprofen, Rheum. Phys. Med. (Suppl.) 10: 108 (Mar. 13) 1970.
5.
AdamsS. S.: Absorption, Distribution and Toxicity of Ibuprofen, Toxicol. Appl. Pharmacol.15: 310 (Sept.) 1969.
6.
The Upjohn Company, Kalamazoo, Michigan, 1974.
7.
AdamsS. S.: Some Biological Properties of 2(4-Isobutylphenyl) Propionic Acid, J. Pharm. Sci.56: 1686, 1967.
8.
KaiserD. G.: GLC Determination of Ibuprofen in Plasma, J. Pharm. Sci.63: 219, 1974.
9.
MillsR. F.: The Metabolism of Ibuprofen, Xenobiotica3: 589 (Sept.) 1973.
10.
MullerK. H.: Ibuprofen in the Treatment of Degenerative and Rheumatoid Joint Conditions, Arzthce. Praxis23: 1993, 1971.
11.
BolosuH.: Treatment with Ibuprofen in Rheumatology, Viata Medicala18: 139, 1971.
12.
OreskovieA.: Supplement to the Medical Treatment of Rheumatoid Arthritis, Rheumatism17: 55, 1970.
13.
GoldbergA. A.: The Long-Term Benefits of Ibuprofen in Rheumatological Practice, Practitioner207: 343 (Sept.) 1971.
14.
JasaniM. K.: Ibuprofen in Rheumatoid Arthritis, Ann. Rheum. Dis.27: 457 (Sept.) 1968.
15.
ChalmersT. M.: Clinical Experience with Ibuprofen in the Treatment of Rheumatoid Arthritis, Ann. Rheum. Dis.26: 513 (Sept.) 1969.
16.
BoardP. L.: Ibuprofen in the Treatment of Rheumatoid Arthritis and Osteoarthritis, Ann. Rheum. Dis.26: 560 (Nov.) 1967.
17.
HuskissonE. C.: A New Look at Ibuprofen, Rheum. Phys. Med. (Suppl) 10: 88 (Mar. 13) 1970.
18.
DornanJ.: Comparison of Ibuprofen and Acetylsalicylic Acid in the Treatment of Rheumatoid Arthritis, Can. Med. Assoc.110: 1370 (June 22) 1974.
19.
PhillipsJ.: A Double-Blind Comparative Trial of Aspirin Preparation and Ibuprofen in General Practice, Br. J. Clin. Prac.26: 113 (Mar.) 1972.
20.
Dick-SmithJ. B.: Ibuprofen, Aspirin and Placebo in the Treatment of Rheumatoid Arthritis — A Double-Blind Clinical Trial, Med. J. Aust. p. 853 (Oct. 25) 1969.
21.
BrooksC. D.: Ibuprofen and Aspirin in the Treatment of Rheumatoid Arthritis, Rheum. Phys. Med. (Suppl) 10: 48 (Mar. 13) 1970.
22.
DickW. C.: Some Aspects in the Quantitation of Inflammation in Joints of Patients Suffering from Rheumatoid Arthritis, Rheum. Phys. Med. (Suppl) 10: 40 (Mar. 13) 1970.
23.
PavelkaK.: Double-Blind Comparison of Ibuprofen and Phenylbutazone in the Short-Term Treatment of Rheumatoid Arthritis, Rheum. Rehab.12: 68 (May) 1973.
24.
GodfreyR.: Effect of Ibuprofen Dosage on Patient Response in Rheumatoid Arthritis, Paper Presented at the VI Pan-American Congress on Rheumatic Diseases, Toronto, Canada (June 16–21) 1974.
25.
BrooksC. D.: Symposium on Ibuprofen — Second Session Discussion, Rheum. Phys. Med. (Suppl) 10: 74 (Mar. 13) 1970.
26.
ThompsonM.: Studies of Gastrointestinal Blood Loss During Ibuprofen Therapy, Rheum. Phys. Med. (Suppl) 10: 104 (Mar. 13) 1970.
27.
ChalmersT. M.: Clinical Experience with Ibuprofen in Rheumatoid Arthritis, Schweiz Med. Wochenschr.101: 280 (Feb. 27) 1971.
28.
CollumL. M.: Ocular Side-Effects of Ibuprofen, Br. J. Ophthal.55: 472 (July) 1971.
29.
GoncalvesL.: Influence of Ibuprofen on Haemostasis in Patients on Anticoagulant Therapy, J. Int. Med. Res.1: 180, 1973.
30.
ThiloD.: A Study of the Effects of the Anti-Rheumatic Drug Ibuprofen on Patients Being Treated with the Oral Anticoagulant Phenprocoumon, J. Int. Med. Res.2: 276, 1974.
31.
Boekhout-MussertM. J.: Influence of Ibuprofen on Oral Anticoagulation with Phenprocoumon, Med. Res.2: 279, 1974.